Is There a Generic for Eohilia?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Eohilia (budesonide). The Orange Book shows its last listed patent expires January 10, 2039 and its last listed exclusivity ends February 9, 2031.

Run it in Rivvi

Map Eohilia and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Eohilia products in the Orange Book

Eohilia products and approved generics
Form and route	Strength	Brand status	Brand TE	Active generics	Generic TE codes
suspension, oral	2MG/10ML	Marketed (Rx)	None	0	None

NDA 213976, held by TAKEDA PHARMACEUTICALS USA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Eohilia patents

Patents listed for Eohilia
Patent	Expires	Covers	Use code	NDA
9119863	November 9, 2026	Method of use	U-3820	213976
8975243	November 9, 2026	Method of use	U-3820	213976
8497258	November 9, 2026	Method of use	U-3820	213976
11197822	November 9, 2026	Drug product	None	213976
11413296	November 9, 2026	Drug product	None	213976
8679545	November 9, 2026	Drug product	None	213976
11357859	November 12, 2028	Method of use	U-3820	213976
10293052	November 22, 2028	Drug product	None	213976
9050368	August 1, 2029	Drug product	None	213976
8324192	August 3, 2029	Method of use	U-3820	213976
11564934	January 10, 2039	Method of use	U-3820	213976
11260064	January 10, 2039	Drug product	None	213976

Eohilia exclusivity

Exclusivity listed for Eohilia
Code	Meaning	Expires	NDA
NP	New product	February 9, 2027	213976
ODE-466	Orphan drug exclusivity	February 9, 2031	213976

Eohilia NDC codes

64764-105

Questions

Is there a generic for Eohilia?

No. The Orange Book lists no active FDA-approved generic (ANDA) for Eohilia (budesonide). The Orange Book shows its last listed patent expires January 10, 2039 and its last listed exclusivity ends February 9, 2031.

What is the generic name for Eohilia?

The active ingredient in Eohilia is budesonide, per the FDA Orange Book.

When does the Eohilia patent expire?

The last patent listed for Eohilia in the Orange Book expires January 10, 2039. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.